{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:57:35Z","timestamp":1792267055131,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00436-025-08600-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:54:26Z","timestamp":1765155266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers"],"prefix":"10.1007","volume":"124","author":[{"given":"Paula Ximena","family":"Pavia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz H.","family":"Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanira","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Clara","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"1","key":"8600_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/infdis\/jiv354","volume":"213","author":"V Adaui","year":"2016","unstructured":"Adaui V, Lye LF, Akopyants NS, Zimic M, Llanos-Cuentas A, Garcia L, Maes I, De Doncker S, Dobson DE, Arevalo J, Dujardin JC, Beverley SM (2016) Association of the endobiont double-stranded RNA virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia. J Infect Dis 213(1):112\u2013121. https:\/\/doi.org\/10.1093\/infdis\/jiv354","journal-title":"J Infect Dis"},{"key":"8600_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0007423","volume":"13","author":"MR Aflatoonian","year":"2019","unstructured":"Aflatoonian MR, Sharifi I, Aflatoonian B, Bamorovat M, Heshmatkhah A, Babaei Z, Almani PGN, Mohammadi MA, Salarkia E, Afshar AA, Sharifi H, Sharifi F, Khosravi A, Khatami M, Arefinia N, Fekri A, Farajzadeh S, Khamesipour A, Mohebali M, Varma RS (2019) Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with Meglumine antimoniate: a cohort study in Iran. PLoS Negl Trop Dis 13:1\u201318. https:\/\/doi.org\/10.1371\/journal.pntd.0007423","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4204","volume":"11","author":"CF Amorim","year":"2019","unstructured":"Amorim CF, Novais FO, Nguyen BT, Misic AM, Carvalho LP, Carvalho EM, Beiting DP, Scott P (2019) Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis. Sci Transl Med 11:eaax4204. https:\/\/doi.org\/10.1126\/scitranslmed.aax4204","journal-title":"Sci Transl Med"},{"key":"8600_CR4","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1086\/518041","volume":"195","author":"J Arevalo","year":"2007","unstructured":"Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Ver\u00e1stegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A (2007) Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 195:1846\u20131851. https:\/\/doi.org\/10.1086\/518041","journal-title":"J Infect Dis"},{"key":"8600_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0192236","volume":"13","author":"M Bamorovat","year":"2018","unstructured":"Bamorovat M, Sharifi I, Aflatoonian MR, Sharifi H, Karamoozian A, Sharifi F, Khosravi A, Hassanzadeh S (2018) Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, Southeast of Iran. PLoS One 13:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0192236","journal-title":"PLoS One"},{"key":"8600_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7705\/biomedica.v8i1-2.1947","volume":"8","author":"SD Beltr\u00e1n","year":"1988","unstructured":"Beltr\u00e1n SD, Vega EC, Arjona AC (1988) Comportamiento de flagelados de La Familia Trypanosomatidae En Dos medios de cultivo modificados. Biomedica 8:21\u201327. https:\/\/doi.org\/10.7705\/biomedica.v8i1-2.1947","journal-title":"Biomedica"},{"key":"8600_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9014726","volume":"2018","author":"TRN Berbert","year":"2018","unstructured":"Berbert TRN, Mello TFPD, Wolf Nassif P, Mota CA, Silveira AV, Duarte GC, Demarchi IG, Aristides SMA, Lonardoni MVC, Vieira Teixeira JJ, Silveira TGV (2018) Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review. Dermatol Res Pract 2018:9014726. https:\/\/doi.org\/10.1155\/2018\/9014726","journal-title":"Dermatol Res Pract"},{"key":"8600_CR8","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.4269\/ajtmh.16-0435","volume":"96","author":"G Brito","year":"2017","unstructured":"Brito G, Dourado M, Guimar\u00e3es LH, Meireles E, Schriefer A, De Carvalho EM, MacHado PRL (2017) Oral pentoxifylline associated with pentavalent antimony: a randomized trial for cutaneous leishmaniasis. Am J Trop Med Hyg 96:1155\u20131159. https:\/\/doi.org\/10.4269\/ajtmh.16-0435","journal-title":"Am J Trop Med Hyg"},{"key":"8600_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4269\/ajtmh.17-0340","volume":"97","author":"M Calvopi\u00f1a","year":"2017","unstructured":"Calvopi\u00f1a M, Cevallos W, Paredes Y, Puebla E, Flores J, Loor R, Padilla J (2017) Intralesional infiltration with Meglumine antimoniate for the treatment of leishmaniasis recidiva cutis in Ecuador. Am J Trop Med Hyg 97:1508\u20131512. https:\/\/doi.org\/10.4269\/ajtmh.17-0340","journal-title":"Am J Trop Med Hyg"},{"key":"8600_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/tmi.13210","volume":"24","author":"SH Carvalho","year":"2019","unstructured":"Carvalho SH, Fr\u00e9zard F, Perei NP, Moura AS, Ramo LMQC, Carvalho GB, Rocha MOC (2019) American tegumentary leishmaniasis in brazil: A critical review of the current therapeutic approach with systemic Meglumine antimoniate and short-term possibilities for an alternative treatment. Trop Med Int Health 24:380\u2013391. https:\/\/doi.org\/10.1111\/tmi.13210","journal-title":"Trop Med Int Health"},{"key":"8600_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005515","volume":"11","author":"M Castro","year":"2017","unstructured":"Castro M, del M Cossio A, Velasco C, Osorio L (2017) Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study. PLoS Negl Trop Dis 11:1\u201314. https:\/\/doi.org\/10.1371\/journal.pntd.0005515","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.01308","volume":"9","author":"F Concei\u00e7\u00e3o-Silva","year":"2018","unstructured":"Concei\u00e7\u00e3o-Silva F, Leite-Silva J, Morgado FN (2018) The binomial parasite-host immunity in the healing process and in reactivation of human tegumentary leishmaniasis. Front Microbiol 9:1\u201317. https:\/\/doi.org\/10.3389\/fmicb.2018.01308","journal-title":"Front Microbiol"},{"key":"8600_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05529-y","volume":"20","author":"CA Correa-C\u00e1rdenas","year":"2020","unstructured":"Correa-C\u00e1rdenas CA, P\u00e9rez J, Patino LH, Ram\u00edrez JD, Duque MC, Romero Y, Cantillo-Barraza O, Rodr\u00edguez O, Alvarado MT, Cruz C, M\u00e9ndez C (2020) Distribution, treatment outcome and genetic diversity of leishmania species in military personnel from Colombia with cutaneous leishmaniasis. BMC Infect Dis 20:1\u201311. https:\/\/doi.org\/10.1186\/s12879-020-05529-y","journal-title":"BMC Infect Dis"},{"key":"8600_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002871","volume":"8","author":"OL Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez OL, Diaz-Toro Y, Ovalle C, Valderrama L, Muvdi S, Rodr\u00edguez I, Gomez MA, Saravia NG (2014) Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS Negl Trop Dis 8:e3026. https:\/\/doi.org\/10.1371\/journal.pntd.0002871","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR15","doi-asserted-by":"publisher","first-page":"e0012156","DOI":"10.1371\/journal.pntd.0012156","volume":"18","author":"OL Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez OL, Rosales-Chilama M, S\u00e1nchez-Hidalgo A, G\u00f3mez P, Rebell\u00f3n-S\u00e1nchez DE, Regli IB, D\u00edaz-Varela M, Tacchini-Cottier F, Saravia NG (2024) Natural resistance to Meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) Panamensis. PLoS Negl Trop Dis 18:e0012156. https:\/\/doi.org\/10.1371\/journal.pntd.0012156","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0009003","volume":"15","author":"MF Garc\u00eda-Bustos","year":"2021","unstructured":"Garc\u00eda-Bustos MF, Gonz\u00e1lez-Prieto G, P\u00e1niz-Mondolfi AE, Parodi C, Becka J, Monroig S, Ramos F, Mora MC, Delgado-Noguera LA, Hashiguchi Y, Jaime D, Moreno S, Ruiz-Morales L, Lemir CG, Barrio A, Oliveira F (2021) Risk factors for antimony treatment failure in American cutaneous leishmaniasis in Northwestern-Argentina. PLoS Negl Trop Dis 15:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0009003","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR17","doi-asserted-by":"publisher","unstructured":"G\u00f3mez MA, Belew AT, Vargas D, Giraldo-Parra L, Rebell\u00f3n-Sanchez D, Alexander T, Sayed NE (2024) Innate biosignature of treatment failure in human cutaneous leishmaniasis. In Review 2:rs.3.rs-4271873. https:\/\/doi.org\/10.21203\/rs.3.rs-4271873\/v1","DOI":"10.21203\/rs.3.rs-4271873\/v1"},{"key":"8600_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/571242","volume":"2011","author":"AK Haldar","year":"2011","unstructured":"Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int 2011:1\u201323. https:\/\/doi.org\/10.4061\/2011\/571242","journal-title":"Mol Biol Int"},{"key":"8600_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-014-0501-y","volume":"7","author":"C Hern\u00e1ndez","year":"2014","unstructured":"Hern\u00e1ndez C, Alvarez C, Gonz\u00e1lez C, Ayala MS, Le\u00f3n CM, Ram\u00edrez JD (2014) Identification of six New World Leishmania species through the implementation of a High-Resolution Melting (HRM) genotyping assay. Parasit Vectors 7:501. https:\/\/doi.org\/10.1186\/s13071-014-0501-y","journal-title":"Parasit Vectors"},{"key":"8600_CR20","first-page":"197","volume":"76","author":"F Jaffar","year":"2018","unstructured":"Jaffar F, Nilforoushzadeh MA, Abdellahi L, Tahmasebi Poor H (2018) Antimonial treatment failure rate in patients with cutaneous leishmaniasis. Tehran Univ Med Sci J 76:197\u2013203","journal-title":"Tehran Univ Med Sci J"},{"key":"8600_CR21","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/bioinformatics\/bts578","volume":"28","author":"K Katoh","year":"2012","unstructured":"Katoh K, Frith MC (2012) Adding unaligned sequences into an existing alignment using MAFFT and LAST. Bioinformatics 28:3144\u20133146. https:\/\/doi.org\/10.1093\/bioinformatics\/bts578","journal-title":"Bioinformatics"},{"key":"8600_CR22","doi-asserted-by":"publisher","first-page":"W256","DOI":"10.1093\/nar\/gkz239","volume":"47","author":"I Letunic","year":"2019","unstructured":"Letunic I, Bork P (2019) Interactive tree of life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 47:W256\u2013W259. https:\/\/doi.org\/10.1093\/nar\/gkz239","journal-title":"Nucleic Acids Res"},{"key":"8600_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/524042","volume":"46","author":"A Llanos-Cuentas","year":"2008","unstructured":"Llanos-Cuentas A, Tullian G, Araujo-Castillo R, Miranda-Verastegu C, Santamaria-Castrellon G, Ramire L, Lazo M, De Doncker S, Boelaert M, Robays J, Dujardin JC, Arevalo J, Chappuis F (2008) Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis 46:223\u2013231. https:\/\/doi.org\/10.1086\/524042","journal-title":"Clin Infect Dis"},{"key":"8600_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.actatropica.2013.11.015","volume":"131","author":"FM Locatelli","year":"2014","unstructured":"Locatelli FM, Cajal SP, Barroso PA, Lauthier JJ, Mora MC, Juarez M, Kato H, Nasser JR, Hashiguchi Y, Korenaga M, Marco JD (2014) The isolation and molecular characterization of Leishmania spp. from patients with American tegumentary leishmaniasis in northwest Argentina. Acta Trop 131:16\u201321. https:\/\/doi.org\/10.1016\/j.actatropica.2013.11.015","journal-title":"Acta Trop"},{"key":"8600_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005713","volume":"11","author":"AJ Mart\u00ednez-Valencia","year":"2017","unstructured":"Mart\u00ednez-Valencia AJ, Daza-Rivera CF, Rosales-Chilama M, Cossio A, Casadiego Rinc\u00f3n EJ, Desai MM, Saravia NG, G\u00f3mez MA (2017) Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis. PLoS Negl Trop Dis 11:1\u201315. https:\/\/doi.org\/10.1371\/journal.pntd.0005713","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1086\/382135","volume":"189","author":"MG Mendon\u00e7a","year":"2004","unstructured":"Mendon\u00e7a MG, de Brit MEF, Rodrigues EHG, Bandeir V, Jardim ML, Abath FGC (2004) Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 189:1018\u20131023. https:\/\/doi.org\/10.1086\/382135","journal-title":"J Infect Dis"},{"key":"8600_CR27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schremp D, Woodhams MD, Von Haeseler A, Lanfear R (2020) IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 37:1530\u20131534. https:\/\/doi.org\/10.1093\/molbev\/msaa015","journal-title":"Mol Biol Evol"},{"key":"8600_CR28","unstructured":"Ministerio de la Protecci\u00f3n Social Rep\u00fablica de Colombia. Instituto Nacional de Salud. Organizaci\u00f3n Panamericana de la Salud (2010) Gu\u00eda de Atenci\u00f3n Cl\u00ednica Integral del Paciente con Leishmaniasis. https:\/\/www.minsalud.gov.co\/Documents\/Salud%20P%C3%BAblica\/Ola%20invernal\/Clinica%20Leishmaniasis.pdf. Accessed 6 de junio de 2025"},{"key":"8600_CR29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.4269\/ajtmh.20-1336","volume":"104","author":"ADC Miranda","year":"2021","unstructured":"Miranda ADC, Gonz\u00e1lez KA, Samudio F, Pineda VJ, Calzada JE, Capitan-Barrios Z, Jim\u00e9nez A, Castillo J, Mendoza Y, Su\u00e1rez JA, Ortiz B, M\u00e9ndez J, Pascale JM, Gr\u00f6g M, Sosa N, Salda\u00f1a A (2021) Molecular identification of parasites causing cutaneous leishmaniasis in Panama. Am J Trop Med Hyg 104:1326\u20131334. https:\/\/doi.org\/10.4269\/ajtmh.20-1336","journal-title":"Am J Trop Med Hyg"},{"key":"8600_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jiph.2012.11.003","volume":"6","author":"M Mohammadzadeh","year":"2013","unstructured":"Mohammadzadeh M, Behnaz F, Golsha Z (2013) Efficacy of glucantime for treatment of cutaneous leishmaniasis in central Iran. J Infect Public Health 6:120\u2013124. https:\/\/doi.org\/10.1016\/j.jiph.2012.11.003","journal-title":"J Infect Public Health"},{"key":"8600_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-3024.2009.01188.x","volume":"32","author":"FN Morgado","year":"2010","unstructured":"Morgado FN, Schubach A, Vasconcellos E, Azeredo-Coutinho RB, Valete-Rosalino CM, Quintella LP, Santos G, Salgueiro M, Palmeiro MR, Concei\u00e7\u00e3o-Silva F (2010) Signs of an in situ inflammatory reaction in scars of human American tegumentary leishmaniasis. Parasite Immunol 32:285\u2013295. https:\/\/doi.org\/10.1111\/j.1365-3024.2009.01188.x","journal-title":"Parasite Immunol"},{"key":"8600_CR32","first-page":"60","volume":"16","author":"A Munir","year":"2008","unstructured":"Munir A, Janjua SA, Hussain I (2008) Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis. Acta Dermatovenerol Croatica: ADC 16:60\u201364","journal-title":"Acta Dermatovenerol Croatica: ADC"},{"key":"8600_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.34172\/jkmu.2023.43","volume":"30","author":"Y Nahidi","year":"2023","unstructured":"Nahidi Y, Mashayekhi Goyonlo V, Dadgarmoghadda M, Hoseininezhad M, Malakifard T, Rastgar Y (2023) Clinical risk factors of systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to the dermatology clinics of Mashhad university of medical Sciences, Iran. J Kerman Univ Med Sci 30:253\u2013260. https:\/\/doi.org\/10.34172\/jkmu.2023.43","journal-title":"J Kerman Univ Med Sci"},{"key":"8600_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","volume":"94","author":"I Okwor","year":"2016","unstructured":"Okwor I, Uzonna J (2016) Social and economic burden of human leishmaniasis. Am J Trop Med Hyg 94:489\u2013493. https:\/\/doi.org\/10.4269\/ajtmh.15-0408","journal-title":"Am J Trop Med Hyg"},{"key":"8600_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0214124","volume":"14","author":"C Ovalle-Bracho","year":"2019","unstructured":"Ovalle-Bracho C, Londo\u00f1o-Barbosa D, Salgado-Almario J, Gonz\u00e1lez C (2019) Evaluating the spatial distribution of Leishmania parasites in Colombia from clinical samples and human isolates (1999 to 2016). PLoS ONE 14:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0214124","journal-title":"PLoS ONE"},{"key":"8600_CR36","first-page":"1","volume":"7","author":"WH Organization","year":"2019","unstructured":"Panamerical Health Organization and, Organization WH (2019) Epidemiological report of the Americas. Rep Leishmaniases 7:1\u20138","journal-title":"Rep Leishmaniases"},{"key":"8600_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10495-007-0052-1","volume":"12","author":"C Paris","year":"2007","unstructured":"Paris C, Bertoglio J, Br\u00e9ard J (2007) Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells. Apoptosis 12:1257\u20131267. https:\/\/doi.org\/10.1007\/s10495-007-0052-1","journal-title":"Apoptosis"},{"issue":"8","key":"8600_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005876","volume":"11","author":"LH Patino","year":"2017","unstructured":"Patino LH, Mendez C, Rodriguez O, Romero Y, Velandia D, Alvarado M, P\u00e9rez J, Duque MC, Ram\u00edrez JD (2017) Spatial distribution, Leishmania species and clinical traits of Cutaneous Leishmaniasis cases in the Colombian army. PLoS Negl Trop Dis 11(8):1\u201315. https:\/\/doi.org\/10.1371\/journal.pntd.0005876","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0004739","volume":"10","author":"JE Perez-Franco","year":"2016","unstructured":"Perez-Franco JE, Cruz-Barrera ML, Robayo ML, Lopez MC, Daza CD, Bedoya A, Mari\u00f1o ML, Saavedra CH, Echeverry MC (2016) Clinical and parasitological features of patients with American cutaneous leishmaniasis that did not respond to treatment with Meglumine antimoniate. PLoS Negl Trop Dis 10:1\u201313. https:\/\/doi.org\/10.1371\/journal.pntd.0004739","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl Trop Dis 11:1\u201324. https:\/\/doi.org\/10.1371\/journal.pntd.0006052","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR41","doi-asserted-by":"publisher","first-page":"e0011316","DOI":"10.1371\/journal.pntd.0011316","volume":"17","author":"L Posada-L\u00f3pez","year":"2023","unstructured":"Posada-L\u00f3pez L, Velez-Mira A, Cantillo O, Castillo-Casta\u00f1eda A, Ram\u00edrez JD, Galati EAB, Galvis-Ovallos F (2023) Ecological interactions of sand flies, hosts, and Leishmania Panamensis in an endemic area of cutaneous leishmaniasis in Colombia. PLoS Negl Trop Dis 17:e0011316. https:\/\/doi.org\/10.1371\/journal.pntd.0011316","journal-title":"PLoS Negl Trop Dis"},{"key":"8600_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep28266","volume":"6","author":"JD Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez JD, Hern\u00e1ndez C, Le\u00f3n CM, Ayala MS, Fl\u00f3rez C, Gonz\u00e1lez C (2016) Taxonomy, diversity, temporal and geographical distribution of cutaneous leishmaniasis in colombia: a retrospective study. Sci Rep 6:1\u201310. https:\/\/doi.org\/10.1038\/srep28266","journal-title":"Sci Rep"},{"key":"8600_CR43","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4269\/ajtmh.17-0628","volume":"100","author":"CA Rigg","year":"2019","unstructured":"Rigg CA, Calzada JE, Salda\u00f1a A, Perea M, Chave LF, Valderrama A (2019) Leishmania spp. infection rate and feeding patterns of sand flies (Diptera: Psychodidae) from a hyperendemic cutaneous leishmaniasis community in Panam\u00e1. Am J Trop Med Hyg 100:798\u2013807. https:\/\/doi.org\/10.4269\/ajtmh.17-0628","journal-title":"Am J Trop Med Hyg"},{"key":"8600_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/s0037-86822006000200001","volume":"39","author":"AM Rodrigues","year":"2006","unstructured":"Rodrigues AM, Hueb M, Rodrigues Dos Santos TAR, Fernandes Fontes CJ (2006) Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate. Rev Soc Bras Med Trop 39:139\u2013145. https:\/\/doi.org\/10.1590\/s0037-86822006000200001","journal-title":"Rev Soc Bras Med Trop"},{"key":"8600_CR45","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1086\/319990","volume":"32","author":"GAS Romero","year":"2001","unstructured":"Romero GAS, De Farias Guerra MV, Paes MG, De Oliveira Mac\u00eado V (2001) Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin Infect Dis 32:1304\u20131312. https:\/\/doi.org\/10.1086\/319990","journal-title":"Clin Infect Dis"},{"key":"8600_CR46","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/infdis\/jir816","volume":"205","author":"LC Rubiano","year":"2012","unstructured":"Rubiano LC, Miranda MC, Muvdi Arenas S, Montero LM, Rodr\u00edguez-Barraquer I, Garcerant D, Prager M, Osorio L, Rojas MX, P\u00e9rez M, Nicholls RS, Saravia NG (2012) Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. J Infect Dis 205:684\u2013692. https:\/\/doi.org\/10.1093\/infdis\/jir816","journal-title":"J Infect Dis"},{"key":"8600_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/0074-02760190111","volume":"114","author":"JN Rugani","year":"2019","unstructured":"Rugani JN, Gontijo CMF, Fr\u00e9zard F, Soares RP, Do Monte-Neto RL (2019) Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake. Mem Inst Oswaldo Cruz 114:1\u20139. https:\/\/doi.org\/10.1590\/0074-02760190111","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"8600_CR48","unstructured":"Sivigila Instituto Nacional de Salud (2025) Leishmaniasis cut\u00e1nea. Portal Sivigila. https:\/\/portalsivigila.ins.gov.co\/Paginas\/Buscador.aspx#. Accessed 6 de junio de 2025"},{"key":"8600_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2028-5","volume":"10","author":"D Steverding","year":"2017","unstructured":"Steverding D (2017) The history of leishmaniasis. Parasit Vectors 10:1\u201310. https:\/\/doi.org\/10.1186\/s13071-017-2028-5","journal-title":"Parasit Vectors"},{"key":"8600_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/S0036-46652008000300005","volume":"50","author":"AC Teixeira","year":"2008","unstructured":"Teixeira AC, Paes MG, Guerra JDO, Prata A, Silva-Vergara ML (2008) Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 50:157\u2013160. https:\/\/doi.org\/10.1590\/S0036-46652008000300005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"8600_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000441120","volume":"7","author":"ID V\u00e9lez","year":"2015","unstructured":"V\u00e9lez ID, Jim\u00e9nez A, V\u00e1squez D, Robledo SM (2015) Disseminated cutaneous leishmaniasis in Colombia: report of 27 cases. Case Rep Dermatol 7:275\u2013286. https:\/\/doi.org\/10.1159\/000441120","journal-title":"Case Rep Dermatol"},{"key":"8600_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molbiopara.2012.03.002","volume":"183","author":"J Walker","year":"2012","unstructured":"Walker J, Gongora R, Vasquez JJ, Drummelsmith J, Burchmore R, Roy G, Ouellette M, Gomez MA, Saravia NG (2012) Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Mol Biochem Parasitol 183:166\u2013176. https:\/\/doi.org\/10.1016\/j.molbiopara.2012.03.002","journal-title":"Mol Biochem Parasitol"},{"key":"8600_CR53","doi-asserted-by":"publisher","unstructured":"Wijnant GJ, Dumetz F, Dirkx L, Bult\u00e9 D, Cuyper B, Van Bocxlaer K, Hendrickx S (2022) Tackling drug resistance and other causes of treatment failure in leishmaniasis. Front Trop Dis 3. https:\/\/doi.org\/10.3389\/fitd.2022.837460","DOI":"10.3389\/fitd.2022.837460"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-025-08600-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:04:03Z","timestamp":1767989043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-025-08600-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["8600"],"URL":"https:\/\/doi.org\/10.1007\/s00436-025-08600-2","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Committee (Project code 2015-048) and the Ethics Committee of the Central Military Hospital (Approval No. 35420; date: 26\/11\/2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"Each patient provided written informed consent before inclusion using a form approved by the Ethics Committee of the Central Military Hospital (Approval No. 35420; date: 26\/11\/2015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}